BB BIOTECH AG 13D and 13G filings for Myovant Sciences Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:17 pm Sale | 2022-12-31 | 13G | MYOVANT SCIENCES LTD COM MYOV | BB BIOTECH AG | 5,872,639 6.000% | -249,400 (-4.07%) | Filing |
| 2022-02-11 4:47 pm Purchase | 2021-12-31 | 13G | MYOVANT SCIENCES LTD COM MYOV | BB BIOTECH AG | 6,122,039 6.600% | 1,365,000 (+28.69%) | Filing |